A contemporary review on the genetic basis of atrial fibrillation
Related Experiment Video
Updated: Apr 28, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Jason D Roberts1, Michael H Gollob1
1University of Ottawa Heart Institute, Ottawa, Ontario.
Insights
Atrial fibrillation (AF) is a common heart rhythm disorder with significant health risks. Understanding its genetic basis and patient heterogeneity is key to developing more effective treatments.
Area of Science:
- Cardiology
- Genetics
- Pharmacology
Background:
- Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, leading to increased risks of heart failure, stroke, and mortality.
- Current AF treatments have limited efficacy, potentially due to a poor understanding of its complex pathophysiology and significant interindividual variability.
- Epidemiological and genetic studies confirm a substantial heritable component to AF, highlighting genetic factors in its diverse manifestations.
Purpose of the Study:
- To explore the genetic underpinnings of atrial fibrillation (AF).
- To investigate the heterogeneity in AF pathophysiology.
- To propose a genotype-guided approach for improved AF management.
Main Methods:
- Review of epidemiological studies on AF heritability.
- Analysis of genetic investigations into AF.
- Conceptual framework for subdividing AF based on genotype.
Main Results:
- AF exhibits considerable interindividual variability in pathophysiology, influenced by genetic factors.
- This heterogeneity likely contributes to the modest efficacy of current AF therapies.
- Subtyping AF by genetic mechanisms offers a potential pathway to personalized treatment.
Conclusions:
- Recognizing the genetic heterogeneity of atrial fibrillation is crucial for advancing treatment strategies.
- A pharmacogenetic approach, tailoring treatments based on an individual's genetic profile, holds promise for significantly improving AF management and patient outcomes.
Abstract:
Atrial fibrillation is the most common sustained cardiac arrhythmia, and affected individuals suffer from increased rates of heart failure, stroke, and death. Despite the enormous clinical burden that it exerts on patients and health care systems, contemporary treatment strategies have only modest efficacy that likely stems from our limited understanding of its underlying pathophysiology. Epidemiological studies have provided unequivocal evidence that the arrhythmia has a substantial heritable component. Subsequent investigations into the genetics underlying atrial fibrillation have suggested that there is considerable interindividual variability in the pathophysiology characterizing the arrhythmia. This heterogeneity may partly account for the poor treatment efficacy of current therapies. Subdividing atrial fibrillation into mechanistic subtypes on the basis of genotype illustrates the heterogeneous nature of the arrhythmia and may ultimately help guide treatment strategies. A pharmacogenetic approach to the management of atrial fibrillation may lead to dramatic improvements in treatment efficacy and improved patient outcomes.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Principles of Pharmacogenetics: Types of Genetic Variants
Mechanism of Cardiac Arrhythmias
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

